vs

Side-by-side financial comparison of UFP TECHNOLOGIES INC (UFPT) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $148.9M, roughly 1.5× UFP TECHNOLOGIES INC). UFP TECHNOLOGIES INC runs the higher net margin — 11.8% vs 5.8%, a 6.0% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 3.4%). Over the past eight quarters, UFP TECHNOLOGIES INC's revenue compounded faster (19.1% CAGR vs 9.5%).

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

UFPT vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.5× larger
UTI
$220.8M
$148.9M
UFPT
Growing faster (revenue YoY)
UTI
UTI
+6.3% gap
UTI
9.6%
3.4%
UFPT
Higher net margin
UFPT
UFPT
6.0% more per $
UFPT
11.8%
5.8%
UTI
Faster 2-yr revenue CAGR
UFPT
UFPT
Annualised
UFPT
19.1%
9.5%
UTI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
UFPT
UFPT
UTI
UTI
Revenue
$148.9M
$220.8M
Net Profit
$17.6M
$12.8M
Gross Margin
28.2%
Operating Margin
14.4%
7.1%
Net Margin
11.8%
5.8%
Revenue YoY
3.4%
9.6%
Net Profit YoY
7.3%
-42.1%
EPS (diluted)
$2.22
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UFPT
UFPT
UTI
UTI
Q4 25
$148.9M
$220.8M
Q3 25
$154.6M
$222.4M
Q2 25
$151.2M
$204.3M
Q1 25
$148.1M
$207.4M
Q4 24
$144.1M
$201.4M
Q3 24
$145.2M
$196.4M
Q2 24
$110.2M
$177.5M
Q1 24
$105.0M
$184.2M
Net Profit
UFPT
UFPT
UTI
UTI
Q4 25
$17.6M
$12.8M
Q3 25
$16.4M
$18.8M
Q2 25
$17.2M
$10.7M
Q1 25
$17.2M
$11.4M
Q4 24
$16.4M
$22.2M
Q3 24
$16.4M
$18.8M
Q2 24
$13.6M
$5.0M
Q1 24
$12.7M
$7.8M
Gross Margin
UFPT
UFPT
UTI
UTI
Q4 25
28.2%
Q3 25
27.7%
Q2 25
28.8%
Q1 25
28.5%
Q4 24
29.2%
Q3 24
28.6%
Q2 24
30.0%
Q1 24
28.6%
Operating Margin
UFPT
UFPT
UTI
UTI
Q4 25
14.4%
7.1%
Q3 25
15.1%
11.2%
Q2 25
16.1%
6.9%
Q1 25
15.6%
8.1%
Q4 24
15.4%
13.6%
Q3 24
17.1%
13.3%
Q2 24
16.3%
4.2%
Q1 24
15.2%
6.1%
Net Margin
UFPT
UFPT
UTI
UTI
Q4 25
11.8%
5.8%
Q3 25
10.6%
8.4%
Q2 25
11.4%
5.2%
Q1 25
11.6%
5.5%
Q4 24
11.4%
11.0%
Q3 24
11.3%
9.6%
Q2 24
12.3%
2.8%
Q1 24
12.1%
4.2%
EPS (diluted)
UFPT
UFPT
UTI
UTI
Q4 25
$2.22
$0.23
Q3 25
$2.11
$0.33
Q2 25
$2.21
$0.19
Q1 25
$2.21
$0.21
Q4 24
$2.08
$0.40
Q3 24
$2.11
$0.35
Q2 24
$1.75
$0.09
Q1 24
$1.64
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UFPT
UFPT
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$20.3M
$162.8M
Total DebtLower is stronger
$135.5M
$101.4M
Stockholders' EquityBook value
$423.9M
$335.9M
Total Assets
$655.1M
$834.0M
Debt / EquityLower = less leverage
0.32×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UFPT
UFPT
UTI
UTI
Q4 25
$20.3M
$162.8M
Q3 25
$18.2M
$169.1M
Q2 25
$14.9M
$70.7M
Q1 25
$14.0M
$96.0M
Q4 24
$13.4M
$172.0M
Q3 24
$16.4M
$161.9M
Q2 24
$16.7M
$115.5M
Q1 24
$11.4M
$116.1M
Total Debt
UFPT
UFPT
UTI
UTI
Q4 25
$135.5M
$101.4M
Q3 25
$146.1M
$87.1M
Q2 25
$163.6M
$73.8M
Q1 25
$163.6M
$94.4M
Q4 24
$189.4M
$120.1M
Q3 24
$212.0M
$125.7M
Q2 24
$35.2M
$137.3M
Q1 24
$34.0M
$141.9M
Stockholders' Equity
UFPT
UFPT
UTI
UTI
Q4 25
$423.9M
$335.9M
Q3 25
$403.9M
$328.1M
Q2 25
$385.5M
$306.8M
Q1 25
$360.7M
$293.9M
Q4 24
$342.8M
$280.0M
Q3 24
$329.1M
$260.2M
Q2 24
$310.2M
$239.4M
Q1 24
$295.0M
$232.6M
Total Assets
UFPT
UFPT
UTI
UTI
Q4 25
$655.1M
$834.0M
Q3 25
$652.8M
$826.1M
Q2 25
$634.7M
$740.8M
Q1 25
$642.6M
$720.4M
Q4 24
$629.0M
$753.8M
Q3 24
$638.5M
$744.6M
Q2 24
$422.4M
$706.0M
Q1 24
$407.7M
$702.1M
Debt / Equity
UFPT
UFPT
UTI
UTI
Q4 25
0.32×
0.30×
Q3 25
0.36×
0.27×
Q2 25
0.42×
0.24×
Q1 25
0.45×
0.32×
Q4 24
0.55×
0.43×
Q3 24
0.64×
0.48×
Q2 24
0.11×
0.57×
Q1 24
0.12×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UFPT
UFPT
UTI
UTI
Operating Cash FlowLast quarter
$16.8M
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.96×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UFPT
UFPT
UTI
UTI
Q4 25
$16.8M
$3.1M
Q3 25
$35.9M
$57.1M
Q2 25
$25.3M
$18.1M
Q1 25
$13.8M
$-789.0K
Q4 24
$24.4M
$23.0M
Q3 24
$19.8M
$67.5M
Q2 24
$11.7M
$10.0M
Q1 24
$10.7M
$-2.5M
Free Cash Flow
UFPT
UFPT
UTI
UTI
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$22.5M
$6.8M
Q1 25
$11.0M
$-11.7M
Q4 24
$21.4M
$19.6M
Q3 24
$17.7M
$60.0M
Q2 24
$8.9M
$3.0M
Q1 24
$8.9M
$-8.4M
FCF Margin
UFPT
UFPT
UTI
UTI
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
14.9%
3.4%
Q1 25
7.4%
-5.7%
Q4 24
14.9%
9.7%
Q3 24
12.2%
30.6%
Q2 24
8.1%
1.7%
Q1 24
8.5%
-4.6%
Capex Intensity
UFPT
UFPT
UTI
UTI
Q4 25
10.1%
Q3 25
7.4%
Q2 25
1.9%
5.5%
Q1 25
1.9%
5.3%
Q4 24
2.1%
1.7%
Q3 24
1.5%
3.8%
Q2 24
2.5%
4.0%
Q1 24
1.6%
3.2%
Cash Conversion
UFPT
UFPT
UTI
UTI
Q4 25
0.96×
0.24×
Q3 25
2.19×
3.04×
Q2 25
1.47×
1.69×
Q1 25
0.80×
-0.07×
Q4 24
1.49×
1.04×
Q3 24
1.21×
3.58×
Q2 24
0.86×
2.01×
Q1 24
0.84×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UFPT
UFPT

Products$145.1M97%
Engineering And Development$1.8M1%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons